Omega Therapeutics Inc (OMGA)
2.505
+0.10
(+4.38%)
USD |
NASDAQ |
Jun 26, 14:06
Omega Therapeutics Accounts Receivable (Quarterly): 0.00 for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 0.00 |
December 31, 2023 | 5.125M |
September 30, 2023 |
Date | Value |
---|---|
June 30, 2023 | |
March 31, 2023 | |
December 31, 2022 | 0.00 |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
Dec 2022
5.125M
Maximum
Dec 2023
1.708M
Average
--
Median
Dec 2022
Accounts Receivable (Quarterly) Benchmarks
Altimmune Inc | 0.307M |
Fate Therapeutics Inc | 0.858M |
Macrogenics Inc | 7.219M |
Ocular Therapeutix Inc | 26.55M |
Viking Therapeutics Inc | -- |